These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33961870)

  • 1. Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy.
    Kano T; Suzuki H; Makita Y; Fukao Y; Suzuki Y
    Kidney Int; 2021 Aug; 100(2):364-376. PubMed ID: 33961870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
    Makita Y; Suzuki H; Kano T; Takahata A; Julian BA; Novak J; Suzuki Y
    Kidney Int; 2020 Feb; 97(2):340-349. PubMed ID: 31748116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine Models of Human IgA Nephropathy.
    Suzuki H; Suzuki Y
    Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
    Myette JR; Kano T; Suzuki H; Sloan SE; Szretter KJ; Ramakrishnan B; Adari H; Deotale KD; Engler F; Shriver Z; Wollacott AM; Suzuki Y; Pereira BJG
    Kidney Int; 2019 Jul; 96(1):104-116. PubMed ID: 31027890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.
    Kajiyama T; Suzuki Y; Kihara M; Suzuki H; Horikoshi S; Tomino Y
    Clin Dev Immunol; 2011; 2011():819646. PubMed ID: 21765852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary zinc is a key environmental modifier in the progression of IgA nephropathy.
    Maiguma M; Suzuki Y; Suzuki H; Okazaki K; Aizawa M; Muto M; Tomino Y
    PLoS One; 2014; 9(2):e90558. PubMed ID: 24587392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy.
    Lee M; Suzuki H; Ogiwara K; Aoki R; Kato R; Nakayama M; Fukao Y; Nihei Y; Kano T; Makita Y; Muto M; Yamada K; Suzuki Y
    Kidney Int; 2023 Nov; 104(5):943-955. PubMed ID: 37648155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
    Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.
    Sanchez-Russo L; Rajasekaran A; Bin S; Faith J; Cravedi P
    Kidney360; 2022 Sep; 3(9):1630-1639. PubMed ID: 36245664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of bone marrow, mucosa and lymphoid tissues in pathogenesis of murine IgA nephropathy.
    Aizawa M; Suzuki Y; Suzuki H; Pang H; Kihara M; Yamaji K; Horikoshi S; Tomino Y
    Contrib Nephrol; 2007; 157():164-8. PubMed ID: 17495457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gut-Renal Connection in IgA Nephropathy.
    Coppo R
    Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy.
    Aizawa M; Suzuki Y; Suzuki H; Pang H; Kihara M; Nakata J; Yamaji K; Horikoshi S; Tomino Y
    PLoS One; 2014; 9(4):e95365. PubMed ID: 24743510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
    Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
    Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 9 affects severity of IgA nephropathy.
    Suzuki H; Suzuki Y; Narita I; Aizawa M; Kihara M; Yamanaka T; Kanou T; Tsukaguchi H; Novak J; Horikoshi S; Tomino Y
    J Am Soc Nephrol; 2008 Dec; 19(12):2384-95. PubMed ID: 18776126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site.
    Wu HY; Nguyen HH; Russell MW
    Scand J Immunol; 1997 Nov; 46(5):506-13. PubMed ID: 9393634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role of IgA receptors in IgA nephropathy.
    Monteiro RC
    Contrib Nephrol; 2007; 157():64-9. PubMed ID: 17495439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS
    J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies.
    Yan D; Rumbeiha WK; Pestka JJ
    Food Chem Toxicol; 1998 Dec; 36(12):1095-106. PubMed ID: 9862652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of podocyte injury in IgA nephropathy.
    Menon MC; Chuang PY; He JC
    Contrib Nephrol; 2013; 181():41-51. PubMed ID: 23689566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
    Hashimoto A; Suzuki Y; Suzuki H; Ohsawa I; Brown R; Hall S; Tanaka Y; Novak J; Ohi H; Tomino Y
    Am J Pathol; 2012 Oct; 181(4):1338-47. PubMed ID: 22871574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.